医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

理学療法

RONGTAI launches Marvel co-branded G20 massage gun in the United States

RONGTAI launches Marvel co-branded G20 massage gun in the United States

ヘルスケア医療機器理学療法　 TimeLine: massage gun in the United States RONGTAI launches Marvel co-branded G2

2022年07月06日

Neuron Physiology ＆ Sports Injury Centre – Why choose a physical therapist with expertise or experience in pediatrics?

Neuron Physiology ＆ Sports Injury Centre – Why choose a physical therapist with expertise or experience in pediatrics?

ヘルスケア理学療法　 TimeLine: in pediatrics Neuron Physiology Sports Injury Centre Why choose a physical therapist with expertise or experience

2022年06月13日

Fist Assist Devices, LLC Announces Australian Distribution Deal and Sales Launch

ヘルスケアヘルス一般医療機器医療用品外科理学療法　 TimeLine: Fist Assist Devices LLC Announces Australian Distribution Deal and Sales Launch

2022年03月15日

Medical Korea 2022 to Discuss Changes and Future Direction of Global Healthcare Industry

Medical Korea 2022 to Discuss Changes and Future Direction of Global Healthcare Industry

ヘルスケアヘルス一般マネージド・ケア心臓学感染症理学療法　 TimeLine: Medical Korea to Discuss Changes and Future Direction of Global Healthcare Industry

2022年03月08日

Medical Korea 2022将讨论全球医疗保健行业的变化和未来方向

Medical Korea 2022将讨论全球医疗保健行业的变化和未来方向

ヘルスケアヘルス一般マネージド・ケア心臓学感染症理学療法　 TimeLine: Medical Korea 变化和未来方向球医疗保健行

2022年03月08日

Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark License Agreement

Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark License Agreement

その他ヘルスヘルスケア医療機器理学療法　 TimeLine: Executes Technology and Trademark License Agreement Myomo Amends China Joint Venture Agreement

2022年01月06日

BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease

BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease

バイオテクノロジーヘルスケア感染症理学療法臨床試験製薬　 TimeLine: BeiGene and EUSA Pharma Announce in China for Idiopathic Multicentric Castleman Disease NMPA Approval of SYLVANT Siltuximab for Injection

2021年12月03日

Invacare Corporation Announces Strategic Realignment of EMEA & APAC Businesses

Invacare Corporation Announces Strategic Realignment of EMEA & APAC Businesses

その他ヘルスバイオテクノロジーヘルスケアヘルス一般マネージド・ケア医療機器理学療法　 TimeLine: APAC Businesses Invacare Corporation Announces Strategic Realignment of EMEA

2021年12月01日